Code of Conduct
In today’s evolving healthcare landscape, it is essential that we uphold the highest standards of integrity, transparency, and patient-centred care. Our Code of Conduct has been carefully crafted to guide our interactions, decisions, and partnerships. At the heart of this code is a steadfast commitment to placing patients at the centre of every decision we make.
We recognise that achieving the best outcomes for patients requires more than just exceptional care. It demands active and respectful collaboration with healthcare professionals, providers, payers, and industry partners. By fostering a culture of ethical partnership, we can create mutually beneficial relationships that align clinical excellence with responsible commercial practices.
Through this Code of Conduct, we reaffirm our commitment to patient well-being, ethical business practices, collaborative solutions and accountability across all areas of our work. Together, we strive to deliver the highest quality of care in a healthcare system that meets the evolving needs of our communities and those we serve.
-
Direct-to-consumer advertising that includes restricted representations must have prior approval from the TGA. Advertising must be accurate, not misleading, and avoid creating unrealistic expectations of benefits. It should not imply endorsement by healthcare professionals or the TGA and must comply with the Therapeutic Goods Advertising Code.
Advertising to HCP’s must be truthful, not misleading, and socially responsible. It should be clearly identifiable as advertising and avoid unsubstantiated claims of uniqueness or superiority. The term "safe" must be appropriately qualified, and "new" can only be used within 12 months of a product's launch.
-
Fee-for-service agreements with healthcare professionals should address valid, documented business needs and must never be intended as incentives for current or anticipated business. Compensation should reflect fair market value, with detailed invoices for services provided. Engagement may include: Research, Advisory Boards, Training and Education or Product Design Input.
Travel, accommodation, and meals for company-sponsored medical events must be modest, directly related to the event, and limited to participants with a genuine professional interest, excluding spouses or family members.
Meetings and events with healthcare professionals should be held at venues that support effective information sharing or educational activities. Recreation or entertainment should not be included in these engagements.
Gifts of branded promotional items, cash, cash-equivalent to healthcare professionals are strictly prohibited. Items having an educational or patient benefit relevant to the healthcare professional’s practice that are modest, low-cost and legally permissible may be provided on occasion.
Sponsorships to attend third-party scientific congress should be provided only through a conference organiser, who is responsible for selecting the healthcare professional recipient and arranging travel and accommodation. Sponsorship funds may cover trainee attendance, reduce meeting costs, or support a faculty member’s honorarium, travel, lodging, and hospitality.
-
Research grants, educational grants, and charitable donations may be provided if:
Objective criteria excludes purchase volume or value from consideration.
Safeguards prevent grants or donations from being tied to purchasing decisions.
The recipient is an institution, with impartial fund allocation processes.
All grants and donations are transparently and comprehensively documented.
-
Interactions with consumers must prioritise non-promotional, educational communication and adherence to ethical standards, specifically:
Requests for medical advice should be refused, directing individuals to their Healthcare Professional.
Educational information on diseases or treatment options can be shared with the public, but promotional content must comply with clause 1.1 Advertising.
Relationships with Health Consumer Organisations is permitted to enhance safe and effective use of medical technologies, aligning with guidelines developed by Medicines Australia and the Consumers Health Forum.
-
As a consultant to global healthcare providers and suppliers, we are committed to complying with all applicable local, regional, and international laws and regulations. We are primarily guided by the MTAA Code of Conduct, but also adhere to the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act, and other relevant anti-bribery and corruption laws worldwide where applicable.
If you have a question, concern or feedback in relation to our conduct, you can contact us for assistance: